Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-21-285547
Filing Date
2021-09-28
Accepted
2021-09-28 16:31:04
Documents
1
Group Members
THOMAS KNIGHT

Document Format Files

Seq Description Document Type Size
1 SC 13G d146836dsc13g.htm SC 13G 41871
  Complete submission text file 0001193125-21-285547.txt   43430
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Subject) CIK: 0001830214 (see all company filings)

EIN.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92710 | Film No.: 211287311
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GINKGO BIOWORKS, INC. 27 DRYDOCK AVENUE, 8TH FLOOR BOSTON MA 02210
Business Address
Knight Thomas F. Jr. (Filed by) CIK: 0001885249 (see all company filings)

Type: SC 13G